PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34638761-3	2021	Previously, we reported that niclosamide targets a metabolic vulnerability in p53-deficient tumours, providing a basis for patient stratification and personalised treatment strategies.	Niclosamide	29-40	tumor protein p53	Homo sapiens	78-81	
34638761-8	2021	Notably, quantitative scoring of drug sensitivity suggests that elimination of its nitro group enhanced the target selectivity of niclosamide against p53 deficiency.	Niclosamide	130-141	tumor protein p53	Homo sapiens	150-153